7B27

RBD domain SARS-CoV2 in complex with neutralizing nanobody NM1230

This is a non-PDB format compatible entry.

Summary for 7B27

• Entry DOI: 10.2210/pdb7b27/pdb
• Descriptor: Surface glycoprotein, neutralizing nanobody NM1230, 2-acetamido-2-deoxy-beta-D-glucopyranose (3 entities in total)
• Functional Keywords: sars-cov2, receptor binding domain, complex structure, neutralizing nanobody, viral protein
• Biological source: Severe acute respiratory syndrome coronavirus 2 (2019-nCoV); More
• Total number of polymer chains: 4
• Total formula weight: 81319.46

Authors

Ostertag, E.,Zocher, G.,Stehle, T. (deposition date: 2020-11-26, release date: 2021-05-12, Last modification date: 2024-01-31)

• Primary citation: Wagner, T.R.,Ostertag, E.,Kaiser, P.D.,Gramlich, M.,Ruetalo, N.,Junker, D.,Haering, J.,Traenkle, B.,Becker, M.,Dulovic, A.,Schweizer, H.,Nueske, S.,Scholz, A.,Zeck, A.,Schenke-Layland, K.,Nelde, A.,Strengert, M.,Walz, J.S.,Zocher, G.,Stehle, T.,Schindler, M.,Schneiderhan-Marra, N.,Rothbauer, U.; NeutrobodyPlex-monitoring SARS-CoV-2 neutralizing immune responses using nanobodies.; Embo Rep., 22:e52325-e52325, 2021; PubMed: 33904225; DOI: 10.15252/embr.202052325

Experimental method

X-RAY DIFFRACTION (2.902 Å)